Key result
Electrical carotid sinus stimulation did not significantly change insulin sensitivity compared to stimulator off (3.3 vs 4.4 (mU/L)(-1) ⋅ min(-1); P=0.7).
Why the study?
Does electrical carotid sinus stimulation improve insulin sensitivity and muscular glucose delivery in patients with treatment-resistant hypertension?
RCT (n=16)
Double-blind
Crossover
Does electrical carotid sinus stimulation improve insulin sensitivity and muscular glucose delivery in patients with treatment-resistant hypertension?
Absolute Event Rate: 3.3% vs 4.4%
p-value: p=0.7
Acute electrical carotid sinus stimulation does not significantly alter whole-body insulin sensitivity or muscular glucose delivery in patients with treatment-resistant hypertension.
No benefit on insulin sensitivity from carotid sinus stimulation in resistant hypertension; challenges hypothesized baroreflex metabolic effects.
Arterial baroreflexes may regulate resistance vessels supplying glucose to skeletal muscle by modulating efferent sympathetic nervous system activity. We hypothesized that selective manipulation of baroreflex activity through electrical carotid sinus stimulation influences insulin sensitivity by changing muscular glucose delivery. We enrolled 16 hypertensive patients who responded to treatment with an electrical carotid sinus stimulator. Patients were submitted to a frequently sampled intravenous glucose tolerance test (FSIGT) with the stimulator on and with the stimulator off on separate days in a randomized, double-blind, crossover study. We monitored interstitial glucose, lactate, and pyruvate in the vastus lateralis muscle using microdialysis. Glucose and insulin concentrations in arterialized venous blood before and during FSIGT were virtually identical with the stimulator on and with the stimulator off. Insulin sensitivity, the primary end point of this study, was 3.3 ± 1.0 (mU/L)(-1) ⋅ min(-1) and 4.4 ± 2.6 (mU/L)(-1) ⋅ min(-1) (on vs. off; P = 0.7). Interstitial glucose, lactate, and pyruvate increased similarly during FSIGT regardless of the stimulator settings. In conclusion, acute changes in baroreceptor stimulation did not elicit significant changes in muscular glucose delivery and whole-body insulin sensitivity. Baroreflex-mediated changes in sympathetic vasomotor tone may have a limited acute effect on muscle glucose metabolism in patients with treatment-resistant hypertension.
No takes yet. Share an insight, caveat, or question.
May et al. (2014) conducted an RCT in Treatment-resistant hypertension (n=16). Electrical carotid sinus stimulation vs. Stimulator off was evaluated on Insulin sensitivity (p=0.7). Electrical carotid sinus stimulation did not significantly change insulin sensitivity compared to stimulator off (3.3 vs 4.4 (mU/L)(-1) ⋅ min(-1); P=0.7).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: